ClinicalTrials.gg
BiologicalDrug

C1 esterase inhibitor (human) clinical trials

Also written CINRYZE and Berinert.

studies test it
17
open now
1
in phase 3
4
first study started
2004

How each study uses C1 esterase inhibitor (human) is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study

Get an email when these change. Save the C1 esterase inhibitor (human) studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Get alerts for these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your alerts, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your alerts. Stop any time.

Approvals

The first approval found in each region, with its record

United States
10 Oct 2008 · Cinryze · BLA 125267 (FDA, Purple Book)
European Union
15 Jun 2011 · Cinryze · EMEA/H/C/001207 (EMA)

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Name

C1 esterase inhibitor (human)
2
C1INH
2

Brand

CINRYZE
6
Berinert
3

Other names

C1 Inhibitor Human
1

In one entry with another drug

Given together, or one or the other

Recombinant Human C1 Inhibitor
4
"rhC1INH"
3
CINRYZE with rHuPH20
2

Studies by the year they started

17 studies that test it; most in 2021 (3)

Studies that test C1 esterase inhibitor (human), by start year
YearStudies
20041
20051
20092
20102
20112
20132
20141
20161
20201
20213
20251

By phase

A phase 1/2 study counts in both.

Phase 1
2
Phase 2
12
Phase 3
4
Phase 4
1

What it is tested for

Each study’s main condition, where its own words name it, so a study counts once.

Who runs them

Industry 11 · Other 6

Shire (7) · Pharming Technologies B.V. (4) · Cedars-Sinai Medical Center (1) · Technical University of Munich (1) · GCS Ramsay Santé pour l'Enseignement et la Recherche (1) · National Institute of Allergy and Infectious Diseases (NIAID) (1) · Leiden University Medical Center (1) · University of Wisconsin, Madison (1)

Often tested with

Tested in the same studies.

Complement C1 Inhibitor Protein (4) · Conestat alfa (4) · Hyaluronidase (human recombinant) (2) · Icatibant (1)

Studies

Open first, then newest update. How each study uses C1 esterase inhibitor (human) is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing it · 17

Given beside what is tested · 1 — C1 esterase inhibitor (human) is usual care or a partner of the new treatment

Codes

What other systems call C1 esterase inhibitor (human) · ClinicalTrials.gg INT004496

  • UNII (FDA) 6KIC4BB60GHUMAN C1-ESTERASE INHIBITORConfirmed FDA, Wikidata
  • RxNorm 809864Confirmed FDA, Wikidata
  • Wikidata Q22075742C1 esterase inhibitor (human)Confirmed FDA, Wikidata
  • DrugBank DB06404One source Wikidata

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.